NCH2.XETRA thyssenkrupp nucera AG & Co. KGaA
- Market cap
- EUR 962M
- P/E
- -
- P/B
- 1.44x
- ROE
- -12.9%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Jun 2026.
Is NCH2.XETRA undervalued?
Graham numberThe Graham number of thyssenkrupp nucera AG & Co. KGaA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
thyssenkrupp nucera AG & Co. KGaA fundamental analysis
No fundamental analysis for thyssenkrupp nucera AG & Co. KGaA yet.
thyssenkrupp nucera AG & Co. KGaA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera AG & Co. KGaA engages in the development, engineering, procurement, commissioning, and licensing of electrolysis technologies in Germany, Saudi Arabia, Sweden, the United States, and internationally. It operates through the Chlor-Alkali (CA) and Green Hydrogen (gH2) segments. The company is involved in the development, planning, and construction of new-build electrolysis plants for producing green hydrogen for industrial applications; provision of service…
Full company profilethyssenkrupp nucera AG & Co. KGaA financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
thyssenkrupp nucera AG & Co. KGaA annual financial statements (EUR; K = thousand, M = million, B = billion, T = trillion)
| Item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|
| Income Statement | |||||||
| Revenue | 254M | 319M | 383M | 653M | 862M | 845M | 457M |
| Gross Profit | 60.3M | 69.1M | 71.4M | 95.0M | 91.0M | 112M | 17.7M |
| Operating Income | 26.7M | 26.9M | 8.82M | 23.8M | -22.0M | -3.30M | -94.7M |
| EBITDA | 31.2M | 30.6M | 15.2M | 25.0M | 20.2M | 35.0M | -67.7M |
| Net Income | 21.7M | 21.3M | 6.00M | 22.5M | 11.0M | 4.60M | -88.9M |
| EPS | 0.17 | 0.17 | 0.05 | 0.21 | 0.09 | 0.04 | -0.71 |
| Balance Sheet | |||||||
| Total Assets | 390M | 416M | 541M | 1.14B | 1.26B | 1.20B | 1.12B |
| Total Liabilities | 207M | 212M | 330M | 400M | 507M | 449M | 433M |
| Shareholders' Equity | 184M | 203M | 211M | 745M | 754M | 753M | 690M |
| Cash & Short-term Investments | 5.33M | 11.7M | 27.3M | 767M | 682M | 684M | 655M |
| Total Debt | 5.68M | 3.98M | 4.12M | 4.60M | 5.00M | 28.2M | 28.0M |
| Cash Flow | |||||||
| Operating Cash Flow | 4.28M | 36.6M | 87.1M | -14.2M | -62.0M | 50.1M | -4.00M |
| Capital Expenditure | 1.82M | 263K | 1.19M | 4.00M | 13.0M | 39.3M | 20.0M |
| Free Cash Flow | 2.45M | 36.3M | 85.9M | -17.0M | -75.0M | 10.8M | -24.0M |
| Ratios | |||||||
| ROE | 11.8% | 10.5% | 2.8% | 3.0% | 1.5% | 0.6% | -12.9% |
| ROA | 5.6% | 5.1% | 1.1% | 2.0% | 0.9% | 0.4% | -7.9% |
| Net Profit Margin | 8.5% | 6.7% | 1.6% | 3.4% | 1.3% | 0.5% | -19.5% |
| Debt to Equity | 0.03x | 0.02x | 0.02x | 0.01x | 0.01x | 0.04x | 0.04x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
thyssenkrupp nucera AG & Co. KGaA dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | EUR 10.0M | 0.08 | 166.7% |
| 2021 | EUR 3.09M | 0.02 | 14.5% |
| 2020 | EUR 10.9M | 0.09 | 50.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Who owns thyssenkrupp nucera AG & Co. KGaA
- Insiders 76.04%
- Institutions 8.48%
- Public & others 15.48%
- Shares outstanding 126M
- Free float 22.6M
thyssenkrupp nucera AG & Co. KGaA company profile
- Company name
- thyssenkrupp nucera AG & Co. KGaA
- Ticker
- NCH2.XETRA
- ISIN
- DE000NCA0001
- Exchange
- XETRA Stock Exchange
- Sector
- Industrials
- Industry
- Machinery
- Employees
- 1,076
- Fiscal year end
- September
- Address
- Freie-Vogel-Str. 385 a, Dortmund, Germany, 44269
- Phone
- 49 231 22972 7100
- Website
- thyssenkrupp-nucera.com
About thyssenkrupp nucera AG & Co. KGaA
thyssenkrupp nucera AG & Co. KGaA engages in the development, engineering, procurement, commissioning, and licensing of electrolysis technologies in Germany, Saudi Arabia, Sweden, the United States, and internationally. It operates through the Chlor-Alkali (CA) and Green Hydrogen (gH2) segments. The company is involved in the development, planning, and construction of new-build electrolysis plants for producing green hydrogen for industrial applications; provision of services for chlor-alkali electrolysis, such as planning and construction of new plants. It also offers the BM 2.7 single-element technology and BiTAC filter press technology. The company was formerly known as thyssenkrupp Uhde Chlorine Engineers GmbH. The company was founded in 1960 and is headquartered in Dortmund, Germany. thyssenkrupp nucera AG & Co. KGaA operates as a subsidiary of thyssenkrupp AG.
thyssenkrupp nucera AG & Co. KGaA management
5- Dr. Werner PonikwarCEO & Chairman of Management Board of thyssenkrupp nucera Management AG · born 1969
- Dr. Stefan HahnCFO & Member of Management Board of thyssenkrupp nucera Management AG · born 1984
- Mr. Klaus OhligCTO & Member of Management Board · born 1968
- Dr. Hendrik FingerHead of Investor Relations
- Ms. Evelin VeitHead of Communications